XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Share-Based Payments: (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Dec. 31, 2018
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Subsidiary or Equity Method Investee [Line Items]            
Share-based payment arrangement, expense   $ 1,220,000   $ 720,000 $ 1,880,000 $ 1,450,000
Decreased income   740,000   460,000 1,180,000 940,000
Weighted average remaining contractual life of options outstanding (in years)         2 years 3 months 4 days  
Weighted average remaining contractual life of options exercisable (in years)         1 year 10 months 14 days  
Aggregate intrinsic value of options outstanding and options exercisable   $ 7,800,000     $ 7,800,000  
Aggregate intrinsic value of options outstanding and options exercisable   6,400,000     6,400,000  
Unrecognized compensation cost   2,200,000     2,200,000  
Adjusted for stock splits 211,955          
Recognized as compensation cost $ 4,800,000 $ 3,400,000     $ 3,100,000  
Interparfums SA Subsidiary [Member] | Employees [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Aggregate shares to offices and managers 26,600 63,281 88,400   63,281  
Number of share distributed         67,372  
Interparfums SA Subsidiary [Member] | Officers and Managers [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Aggregate shares to offices and managers 133,000          
Equity Option [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Fair value of shares vested         $ 100,000 $ 900,000
Equity Option [Member] | Minimum [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Options vesting period     4 years      
Equity Option [Member] | Maximum [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Options vesting period     5 years